MeSH Review:
CD4 Lymphocyte Count
Koziel,
Eichbaum,
Kruskal,
Pinkston,
Rogers,
Armstrong,
Richards,
Rose,
Ezekowitz,
Masquelier,
Descamps,
Carrière,
Ferchal,
Collin,
Denayrolles,
Ruffault,
Chanzy,
Izopet,
Buffet-Janvresse,
Schmitt,
Race,
Fleury,
Aboulker,
Yeni,
Brun-Vézinet,
Schooley,
Clumeck,
Haubrich,
Thompson,
Danner,
van Der Ende,
Sereni,
Antunes,
Blake,
Myers,
Tisdale,
Millard,
Mustafa,
Nacci,
Easterbrook,
Rostron,
Ives,
Troop,
Gazzard,
Rowland-Jones,
Bitnun,
Sochett,
Babyn,
Holowka,
Stephens,
Read,
King,
- Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group. Cooper, D.A., Gatell, J.M., Kroon, S., Clumeck, N., Millard, J., Goebel, F.D., Bruun, J.N., Stingl, G., Melville, R.L., González-Lahoz, J. N. Engl. J. Med. (1993)
- Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. O'Brien, W.A., Hartigan, P.M., Martin, D., Esinhart, J., Hill, A., Benoit, S., Rubin, M., Simberkoff, M.S., Hamilton, J.D. N. Engl. J. Med. (1996)
- A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. Markowitz, M., Saag, M., Powderly, W.G., Hurley, A.M., Hsu, A., Valdes, J.M., Henry, D., Sattler, F., La Marca, A., Leonard, J.M. N. Engl. J. Med. (1995)
- A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study. Hamilton, J.D., Hartigan, P.M., Simberkoff, M.S., Day, P.L., Diamond, G.R., Dickinson, G.M., Drusano, G.L., Egorin, M.J., George, W.L., Gordin, F.M. N. Engl. J. Med. (1992)
- Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis. Pol, S., Romana, C.A., Richard, S., Amouyal, P., Desportes-Livage, I., Carnot, F., Pays, J.F., Berthelot, P. N. Engl. J. Med. (1993)
- Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin. Brew, B.J., Dunbar, N., Pemberton, L., Kaldor, J. J. Infect. Dis. (1996)
- Characteristics of HIV-infected men with low serum testosterone levels. Kopicko, J.J., Momodu, I., Adedokun, A., Hoffman, M., Clark, R.A., Kissinger, P. International journal of STD & AIDS. (1999)
- Discontinuation of prophylaxis for Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS. El-Sadr, W.M., Burman, W.J., Grant, L.B., Matts, J.P., Hafner, R., Crane, L., Zeh, D., Gallagher, B., Mannheimer, S.B., Martinez, A., Gordin, F. N. Engl. J. Med. (2000)
- The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. Bozzette, S.A., Berry, S.H., Duan, N., Frankel, M.R., Leibowitz, A.A., Lefkowitz, D., Emmons, C.A., Senterfitt, J.W., Berk, M.L., Morton, S.C., Shapiro, M.F. N. Engl. J. Med. (1998)
- Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. Gulick, R.M., Mellors, J.W., Havlir, D., Eron, J.J., Gonzalez, C., McMahon, D., Richman, D.D., Valentine, F.T., Jonas, L., Meibohm, A., Emini, E.A., Chodakewitz, J.A. N. Engl. J. Med. (1997)
- Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. Collier, A.C., Coombs, R.W., Schoenfeld, D.A., Bassett, R.L., Timpone, J., Baruch, A., Jones, M., Facey, K., Whitacre, C., McAuliffe, V.J., Friedman, H.M., Merigan, T.C., Reichman, R.C., Hooper, C., Corey, L. N. Engl. J. Med. (1996)
- A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. Saag, M.S., Emini, E.A., Laskin, O.L., Douglas, J., Lapidus, W.I., Schleif, W.A., Whitley, R.J., Hildebrand, C., Byrnes, V.W., Kappes, J.C. N. Engl. J. Med. (1993)
- Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. Koziel, H., Eichbaum, Q., Kruskal, B.A., Pinkston, P., Rogers, R.A., Armstrong, M.Y., Richards, F.F., Rose, R.M., Ezekowitz, R.A. J. Clin. Invest. (1998)
- Safety and activity of saquinavir in HIV infection. Kitchen, V.S., Skinner, C., Ariyoshi, K., Lane, E.A., Duncan, I.B., Burckhardt, J., Burger, H.U., Bragman, K., Pinching, A.J., Weber, J.N. Lancet (1995)
- A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience. Schooley, R.T., Clumeck, N., Haubrich, R., Thompson, M., Danner, S.A., van Der Ende, M.E., Sereni, D., Antunes, F., Blake, D., Myers, R.E., Tisdale, M., Millard, J., Mustafa, N., Nacci, P. Antivir. Ther. (Lond.) (2001)
- Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Hughes, M.D., Johnson, V.A., Hirsch, M.S., Bremer, J.W., Elbeik, T., Erice, A., Kuritzkes, D.R., Scott, W.A., Spector, S.A., Basgoz, N., Fischl, M.A., D'Aquila, R.T. Ann. Intern. Med. (1997)
- Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group. Mannucci, P.M., Brettler, D.B., Aledort, L.M., Lusher, J.M., Abildgaard, C.F., Schwartz, R.S., Hurst, D. Blood (1994)
- Viraemia and p24 antigenaemia are independent risk factors for the emergency of a zidovudine-resistant genotype in nucleoside analogue-treated HIV-1 infection. Relimpio, F., Rey, C., Pineda, J.A., Leal, M., Caruz, A., Sánchez-Quijano, A., Lissen, E. Antivir. Ther. (Lond.) (1997)
- Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over study. Masquelier, B., Descamps, D., Carrière, I., Ferchal, F., Collin, G., Denayrolles, M., Ruffault, A., Chanzy, B., Izopet, J., Buffet-Janvresse, C., Schmitt, M.P., Race, E., Fleury, H.J., Aboulker, J.P., Yeni, P., Brun-Vézinet, F. Antivir. Ther. (Lond.) (1999)
- Influence of single-nucleotide polymorphisms in the multidrug resistance-1 gene on the cellular export of nelfinavir and its clinical implication for highly active antiretroviral therapy. Zhu, D., Taguchi-Nakamura, H., Goto, M., Odawara, T., Nakamura, T., Yamada, H., Kotaki, H., Sugiura, W., Iwamoto, A., Kitamura, Y. Antivir. Ther. (Lond.) (2004)
- Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study. Kaslow, R.A., Phair, J.P., Friedman, H.B., Lyter, D., Solomon, R.E., Dudley, J., Polk, B.F., Blackwelder, W. Ann. Intern. Med. (1987)
- CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis. Herbeuval, J.P., Grivel, J.C., Boasso, A., Hardy, A.W., Chougnet, C., Dolan, M.J., Yagita, H., Lifson, J.D., Shearer, G.M. Blood (2005)
- Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study Group. Kuritzkes, D.R., Parenti, D., Ward, D.J., Rachlis, A., Wong, R.J., Mallon, K.P., Rich, W.J., Jacobson, M.A. AIDS (1998)
- Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children. Bitnun, A., Sochett, E., Babyn, P., Holowka, S., Stephens, D., Read, S., King, S.M. AIDS (2003)
- Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group. Schwartländer, B., Bek, B., Skarabis, H., Koch, J., Burkowitz, J., Koch, M.A. AIDS (1993)
- A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group. Volberding, P.A., Lagakos, S.W., Grimes, J.M., Stein, D.S., Rooney, J., Meng, T.C., Fischl, M.A., Collier, A.C., Phair, J.P., Hirsch, M.S. N. Engl. J. Med. (1995)
- The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. Katzenstein, D.A., Hammer, S.M., Hughes, M.D., Gundacker, H., Jackson, J.B., Fiscus, S., Rasheed, S., Elbeik, T., Reichman, R., Japour, A., Merigan, T.C., Hirsch, M.S. N. Engl. J. Med. (1996)
- A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. Hardy, W.D., Feinberg, J., Finkelstein, D.M., Power, M.E., He, W., Kaczka, C., Frame, P.T., Holmes, M., Waskin, H., Fass, R.J. N. Engl. J. Med. (1992)
- Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells. Sereti, I., Martinez-Wilson, H., Metcalf, J.A., Baseler, M.W., Hallahan, C.W., Hahn, B., Hengel, R.L., Davey, R.T., Kovacs, J.A., Lane, H.C. Blood (2002)
- Impairment of B-lymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1-disease. Conge, A.M., Tarte, K., Reynes, J., Segondy, M., Gerfaux, J., Zembala, M., Vendrell, J.P. AIDS (1998)
- Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy. Blanco, J., Cabrera, C., Jou, A., Ruiz, L., Clotet, B., Esté, J.A. AIDS (1999)
- Chemokine receptor polymorphisms and human immunodeficiency virus disease progression. Easterbrook, P.J., Rostron, T., Ives, N., Troop, M., Gazzard, B.G., Rowland-Jones, S.L. J. Infect. Dis. (1999)
- Evaluation of the putative role of C-C chemokines as protective factors of HIV-1 infection in seronegative hemophiliacs exposed to contaminated hemoderivatives. Barretina, J., Blanco, J., Gutiérrez, A., Puig, L., Altisent, C., Espanol, T., Caragol, I., Clotet, B., Esté, J.A. Transfusion (2000)
- Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. Kovacs, J.A., Vogel, S., Albert, J.M., Falloon, J., Davey, R.T., Walker, R.E., Polis, M.A., Spooner, K., Metcalf, J.A., Baseler, M., Fyfe, G., Lane, H.C. N. Engl. J. Med. (1996)
- Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Mellors, J.W., Muñoz, A., Giorgi, J.V., Margolick, J.B., Tassoni, C.J., Gupta, P., Kingsley, L.A., Todd, J.A., Saah, A.J., Detels, R., Phair, J.P., Rinaldo, C.R. Ann. Intern. Med. (1997)
- Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group. Spruance, S.L., Pavia, A.T., Mellors, J.W., Murphy, R., Gathe, J., Stool, E., Jemsek, J.G., Dellamonica, P., Cross, A., Dunkle, L. Ann. Intern. Med. (1997)
- Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings. Badri, M., Wood, R. AIDS (2003)
- High incidence of atypical mycobacteriosis in African HIV-infected adults with low CD4 cell counts: a 6-year cohort study in Côte d'Ivoire. Bonard, D., Messou, E., Seyler, C., Vincent, V., Gabillard, D., Anglaret, X. AIDS (2004)